seobhushan - PowerPoint PPT Presentation

About This Presentation
Title:

seobhushan

Description:

In October 2017, Abbott, a prominent player in the Coronary stents market, obtained the CE Mark for its XIENCE Sierra everolimus-eluting coronary stent system. The reception of the CE Mark enabled the sale of the device in the EU and other nations that recognize the mark. Advancements in this XIENCE generation, which is recognized for its exceptional safety, comprised features that facilitate cardiologists in the successful completion of complex procedures that now account for nearly 70 per cent of cases. The product makes it easier for cardiologists to unblock and access difficult-to-reach lesions and its new features comprise small-diameters, thinner profile, longer lengths, and increased flexibility. Get sample copy of this research report @ – PowerPoint PPT presentation

Number of Views:4
Updated: 15 March 2021
Slides: 8
Provided by: seobhushan
Category:
Tags:

less

Transcript and Presenter's Notes

Title: seobhushan


1
Coronary Stents Market is Projected to grow at a
3.9 CAGR by 2027
2
Key Insights from Coronary Stents Market
  • The Cardiac stents segment is forecasted to
    depict appreciable growth of 4.6 per cent through
    2027. This upsurge is on account of the reduced
    cost of post cardiac surgeries, rising prevalence
    of coronary artery diseases, and surging focus on
    enhancing the life expectancy of patients. The
    outreach of specialized cardiac centers to the
    extensive patient pool and the availability of
    advanced treatment alternatives are set to
    bolster market growth through the forecasted
    period.
  • The bioresorbable vascular scaffold segment held
    a substantial share of USD 416.0 million of the
    overall coronary stents market value. A rise in
    the number of minimally invasive surgeries owing
    to the constantly evolving technology has been
    the major reason for increased adoption. The
    bioresorbable vascular scaffold decreases
    complications comprising thrombosis and
    inflammation and helps in the restoration of
    normal vasomotion and improvement of abnormal
    endothelial function.
  • .

3

Latest Research Report On Coronary Stents Market_at_
https//www.gminsights.com/industry-analysis/coro
nary-stents-market Request for a sample of
this research report _at_ https//www.gminsights.com/
request-sample/detail/2966
4
Regional Insights in Coronary Stents Market
  • The Asia Pacific coronary stents market held
    more than 50 per cent of the overall revenue in
    2020 and is projected to record remarkable growth
    over the analysis period. The high rate of growth
    is on account of the rising prevalence of chronic
    diseases including cardiac diseases and cancer.
    There is also an increase in the demand for
    minimally invasive surgical procedures owing to
    numerous advantages comprising shorter hospital
    stays, small scars, short recovery time, and low
    risk of infection. Various regulations, for
    instance, price capping in India are expected to
    increase the acceptance of the stents of local
    manufacturers.

5
Major Companies in Coronary Stents Market
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biosensors International Group
  • Biotronik SE Co.
  • Boston Scientific Corporation
  • Elixir Medical Corporation
  • Medtronic Plc
  • Meril Life Science
  • MicroPort Scientific Corporation
  • Terumo Corporation

6
Industry Coverage

7
Stay In Touch Website www.gminsights.com Soci
al Media
Write a Comment
User Comments (0)
About PowerShow.com